Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
- Resource Type
- Article
- Source
- The Lancet; July-August 2017, Vol. 390 Issue: 10093 p457-468, 12p
- Subject
- Language
- ISSN
- 01406736; 1474547X